No Data
No Data
Maibo Pharmaceutical appoints Jialin Cen as non-executive director B.
Mycopharmaceuticals-B (02181) announced that Mr. Shen Jialin will be appointed as a non-executive director from July 10, 2024; Dr. Tao Qian will be appointed as an independent non-executive director; Dr. Qian Weizhu, the current non-executive director of the company, will be transferred to the executive director position and appointed as the vice president of the company; and Mr. Li Yunfeng will be appointed as the vice president of the company and no longer serve as the chief financial officer.
Milestone Pharmaceuticals-B (02181.HK) appoints Janice Shan as non-executive director.
On July 10th, Gelonhui announced that starting from July 10th, 2024: (i) Mr. Cen Jialin will be appointed as a non-executive director; (ii) Dr. Tao Qian will be appointed as an independent non-executive director; (iii) Dr. Qian Weizhu, the current non-executive director of the company, will be transferred to the position of executive director and will be appointed as the company's vice president; and (iv) Mr. Li Yunfeng will be appointed as the company's vice president and will no longer serve as the company's chief financial officer.
Express News | Mabpharm Ltd - Li Yunfeng Will No Longer Hold Position of CFO
Express News | Mabpharm Ltd - Li Yunfeng Appointed as a Vice President
Express News | Mabpharm Ltd - Qian Weizhu Re-Designated as Executive Director
Express News | Mabpharm Ltd - Qian Weizhu Will Be Appointed as Vice President
No Data